Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Case Reports in Genetics|December 2, 2024
Geroderma Osteodysplastica With Concomitant Transposition of Great Vessels: A Case Report and Literature ReviewCharbel Saad, Christine Aoun, Charbel Iskandar, et al.
The American Journal of the Medical Sciences|November 15, 2005
Panaortitis: diagnosis via fluorodeoxyglucose positron emission tomographyRonen Zalts, Shadi Hamoud, Rachel Bar-Shalom, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|March 8, 2002
Antiatherosclerotic effects of licorice extract supplementation on hypercholesterolemic patients: increased resistance of LDL to atherogenic modifications, reduced plasma lipid levels, and decreased systolic blood pressureBianca Fuhrman, Nina Volkova, Marielle Kaplan, et al.
Atherosclerosis|October 12, 2005
Macrophage foam-cell formation in streptozotocin-induced diabetic mice: stimulatory effect of glucoseTony Hayek, Khitam Hussein, Michael Aviram, et al.
Biomed Research International|December 12, 2017
Heparanase Inhibition Reduces Glucose Levels, Blood Pressure, and Oxidative Stress in Apolipoprotein E Knockout MiceShadi Hamoud, Rabia Shekh Muhammad, Niroz Abu-Saleh, et al.
Journal of Cardiovascular Pharmacology|December 12, 2003
Omapatrilat decreased macrophage oxidative status and atherosclerosis progression in atherosclerotic apolipoprotein E-deficient miceTony Hayek, Shadi Hamoud, Shlomo Keidar, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 4, 2003
Tissue angiotensin-converting-enzyme (ACE) deficiency leads to a reduction in oxidative stress and in atherosclerosis: studies in ACE-knockout mice type 2Tony Hayek, Elsa Pavlotzky, Shadi Hamoud, et al.
Atherosclerosis|January 10, 2014
Pomegranate extract (POMx) decreases the atherogenicity of serum and of human monocyte-derived macrophages (HMDM) in simvastatin-treated hypercholesterolemic patients: a double-blinded, placebo-controlled, randomized, prospective pilot studyShadi Hamoud, Tony Hayek, Nina Volkova, et al.
Journal of Cardiovascular Pharmacology|May 31, 2003
Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein E-deficient miceShlomo Keidar, Tony Hayek, Marielle Kaplan, et al.
Circulation|May 5, 2004
Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosteroneShlomo Keidar, Marielle Kaplan, Elsa Pavlotzky, et al.
Pageof 7